Mankind Pharma Ltd Announces 35th AGM and Annual Report for FY25-26

Mankind Pharma Ltd has announced its 35th Annual General Meeting (AGM) scheduled for August 4, 2026, to be held via Video Conferencing. The company has also released its Annual Report for the financial year 2025-26. Key agenda items include the adoption of standalone and consolidated financial statements, the reappointment of a director retiring by rotation, and the re-appointment of Mr. Satish Kumar Sharma as Whole Time Director for a further period of five years. The notice and annual report are available on the company's website, and e-voting facilities will be provided to members.